Bayer taps PeptiDream in multi-target discovery alliance
Kanagawa-based PeptiDream’s drug discovery alliance with Bayer AG is a deal potentially worth up to $1.11bn, according to the company.
Archives for November 20, 2017
Report: CRO turnover spikes outside the US, remains steady stateside
An increasing number of clinical trials and a decreasing amount of unemployment are creating a significant talent demand as the contract research industry continues to experience employee turnover.
UK drug development firm RxCelerate expands in US
Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery, and preclinical safety services throughout North America.
IPEC rolls out guide to reflect changing pharma excipient landscape
The International Pharmaceutical Excipient Council (IPEC) has updated its Quality Agreement guidelines to reflect changing regulatory expectations and global nature of supply chains.
Researchers tweak opioid compounds to combat overdose
Scientists have developed opioid pain relievers that do not slow or stop breathing – the cause of opiate overdose – they say could reduce the risk of accidental death.
Corium close to partnering on transdermal Alzheimer’s drug
Corium says it is in talks with commercialisation partners for its transdermal Alzheimer’s disease candisate Corplex Donepezil ahead of a potential 2019 launch.